Topics

Apellis Pharmaceuticals, Inc. Company Profile

21:51 EDT 21st September 2019 | BioPortfolio


News Articles [860 Associated News Articles listed on BioPortfolio]

Apellis Forms Collaboration with SFJ Pharmaceuticals

For APL-2 in hematologic indications; Apellis to receive up to $120 million in upfront and near-term milestone payments

Apellis Pharma : Scaling New Highs

Shares of Apellis Pharmaceuticals Inc. (APLS), which touched an all-time high of $30.25 in intraday trading yesterday, are up 132 percent year-to-date.

Apellis, SFJ Pharma to develop candidate for hematologic disorders

Apellis Pharmaceuticals has partnered with SFJ Pharmaceuticals to develop C3 inhibitor candidate APL-2, indicated for blood d -More- 

Apellis and SFJ Pharmaceuticals Collaborate for APL-2 in Hematologic Indications

WALTHAM Mass., and CRESTWOOD, Ky., Feb. 28, 2019 (GLOBE NEWSWIRE) —  Apellis Pharmaceuticals Inc., (Nasdaq:APLS) a clinical-stage biopharmaceutical company focused on the development of novel ...

Apellis' paroxysmal nocturnal hemoglobinuria drug fast-tracked by FDA

Apellis Pharmaceuticals' APL-2 received fast-track designation from the FDA.  -More- 

Apellis Pharmaceuticals, Inc.: Apellis Pharmaceuticals präsentiert Daten aus der laufenden APL-2 Phase-2-Studie bei Patienten mit Kälteagglutininkrankheit und warmer autoimmun-hämolytischer Anämie beim 24, Kongress der European Hematology Association

CRESTWOOD, Ky. and WALTHAM Mass., June 16, 2019Inc.-Studie von APL-2 bei Patienten mit autoimmuner hämolytischer Anämie (AIHA), einschließlich Kälteagglutininkrankheit (CAD) und warmer autoimmun-h...

Apellis Pharmaceuticals Announces Collaboration with SFJ Pharmaceuticals® for APL-2 in Hematologic Indications

Apellis to receive up to $120 million in upfront and near-term milestone payments, with the potential for additional payments subject to mutual agreement Apellis retains exclusive worldwide commerc...

Apellis Pharmaceuticals, Inc.: Apellis Pharmaceuticals Presents Data from Ongoing APL-2 Phase 2 Study in Patients with Cold Agglutinin Disease and Warm Antibody Autoimmune Hemolytic Anemia at 24th European Hematology Association (EHA) Congress

CRESTWOOD, Ky. and WALTHAM Mass., June 15, 2019Inc.study of APL-2 in patients with autoimmune hemolytic anemia (AIHA), including cold agglutinin disease (CAD) and warm antibody autoimmune hemolytic...

Drugs and Medications [0 Results]

None

PubMed Articles [137 Associated PubMed Articles listed on BioPortfolio]

Mytilidae as model organisms in the marine ecotoxicology of pharmaceuticals - A review.

Growing production and consumption of pharmaceuticals is a global problem. Due to insufficient data on the concentration and distribution of pharmaceuticals in the marine environment, there are no app...

Occurrence and ranking of pharmaceuticals in the major rivers of China.

Residual pharmaceuticals have received widespread attention worldwide due to their continuous release and potential hazard to the environment. As a result of rapid development and a large population, ...

Occurrence and distribution of pharmaceuticals in raw, finished, and drinking water from seven large river basins in China.

The occurrence of pharmaceuticals in the drinking water is a growing concern in China. In this study, we determined the concentration and distribution of 59 selected pharmaceuticals in raw, finished, ...

U.S. Emergency Department Visits Resulting From Nonmedical Use of Pharmaceuticals, 2016.

National data on morbidity from nonmedical use of pharmaceuticals are limited. This study used nationally representative, public health surveillance data to characterize U.S. emergency department visi...

Simultaneous aqueous chlorination of amine-containing pharmaceuticals.

Amine-containing pharmaceuticals such as acetaminophen, diclofenac, and sulfamethoxazole are the most often detected pharmaceuticals in wastewater and other aquatic environments. Amine-containing phar...

Clinical Trials [244 Associated Clinical Trials listed on BioPortfolio]

Bioequivalence Study of Torrent Pharmaceuticals's Ltd's Nebivolol 20 mg Tablet

Subjects to compare the single dose bioavailability of Torrent's Nebivolol Tablets 20 mg and Bystolic 20 mg Tablets of Forest Pharmaceuticals Inc., USA. Dosing periods of studies were sepa...

Bioequivalence Study of Torrent Pharmaceuticals Ltd's Nebivolol 20 mg Tablet

Subjects to compare the single dose bioavailability of Torrent's Nebivolol Tablets 20 mg and Bystolic®20 mg Tablets of Forest Pharmaceuticals Inc., USA. Dosing periods of studies were sep...

Study Comparing Citalopram Hydrobromide Tablets 40 mg (Torrent Pharmaceuticals Ltd) and RLD Tablets 40 mg (Manufactured By Forest Pharmaceuticals Inc, Missouri) in 24+2 Normal Healthy Male Subjects in Fed Condition

- Objective: - The objective of this study is to compare the rate and extent of absorption of the Test Product, Citalopram Hydrobromide 40 mg (Torrent Pharmaceutical Li...

Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Rosuvastatin Calcium Tablets Under Fed Conditions

Subjects to compare the single dose bioavailability of Torrent's Rosuvastatin Calcium Tablets 40 mg and Crestor® 40 mg Tablets of AstraZeneca Pharmaceuticals LP, USA. Dosing periods of st...

Cilostazol 50 mg Tablets Under Fasting Conditions

This study will compare the relative bioavailability (rate and extent of absorption) of 50 mg Cilostazol Tablets manufactured by TEVA Pharmaceuticals Industries Ltd. and distributed by TEV...

Companies [1383 Associated Companies listed on BioPortfolio]

Apellis Pharmaceuticals, Inc.

Maelor Pharmaceuticals Ltd.

Maelor is a publicly listed (AIM:MLR) specialist critical care pharmaceuticals and devices company. The Company has developed an expertise in bringing both pharmaceuticals and devices to the market as...

Excaliard Pharmaceuticals, Inc.

Excaliard Pharmaceuticals, Inc., is a venture capital-funded biotechnology company founded in 2007 focused on the development and commercialization of novel and innovative drugs for the amelioration o...

Serenity Pharmaceuticals

Founded in 2007 and located in Milford, Pennsylvania, Serenity Pharmaceuticals is focused on developing products that address urinary conditions that impact the health and well-be...

Avanir Pharmaceuticals

AVANIR Pharmaceuticals, formerly LIDAK Pharmaceuticals, is a development stage company organized to discover, develop, and market novel therapeutic products to treat human diseases.

More Information about "Apellis Pharmaceuticals, Inc." on BioPortfolio

We have published hundreds of Apellis Pharmaceuticals, Inc. news stories on BioPortfolio along with dozens of Apellis Pharmaceuticals, Inc. Clinical Trials and PubMed Articles about Apellis Pharmaceuticals, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Apellis Pharmaceuticals, Inc. Companies in our database. You can also find out about relevant Apellis Pharmaceuticals, Inc. Drugs and Medications on this site too.

Quick Search

Corporate Database Quicklinks



Searches Linking to this Company Record